Cognition Therapeutics's total assets for Q3 2024 were $27.58M, a decrease of -19.76% from the previous quarter. CGTX total liabilities were $13.10M for the fiscal quarter, a 15.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.